ArticleClinical & experimental metastasis2016

MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.

I Made Winarsa Ruma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.